Ameritas Investment Partners, Inc. Humacyte, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 8,612 shares of HUMA stock, worth $35,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,612
Previous 8,612
-0.0%
Holding current value
$35,567
Previous $41,000
12.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
36.2MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$29.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$23.1 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$19.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.23 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $425M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...